Chai Discovery, the AI company building a computer-aided design suite for molecules, today announced a collaboration with Eli ...

Amgen (NASDAQ:AMGN) remains a major biotechnology name as nasdaq composite discussions highlight healthcare innovation.

Synartro is advancing the candidate drug SYN321, a novel intra-articular treatment for knee osteoarthritis, through a phase 1/2a clinical study focused on safety, tolerability, PK, ...

Aevumed, Inc., a MedTech company pioneering innovative orthopedic solutions, today announced that Dr. Surena Namdari will lead AI training for AiTRIUMtm Surgical Intelligence, the first ...

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

CAMBRIDGE, Mass., Jan. 8, 2026 /PRNewswire/ -- Pfizer Inc. and Boltz, PBC, an applied AI research lab, today announced a strategic collaboration to empower scientists across the company with ...

Company to present Tuesday, January 13th at 10:00 a.m. PT / 1:00 p.m. ETGAITHERSBURG, Md., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Elutia Inc.

Düsseldorf District Court issues preliminary injunction against Beijing Hanbaihan Medical Devices Co., Ltd. regarding ...

LEXINGTON, Mass. and AMSTERDAM, Jan. 09, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing ...

Shares of UniQure were higher after the gene therapy company said it had scheduled a Type A meeting with the Food and Drug Administration to discuss a Biologics License Application for the company's ...

LEXINGTON, Mass. and AMSTERDAM, Jan. 09, 2026N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced a Type A mee ...

Learn more about whether Alphatec Holdings, Inc. or Neogen Corporation is a better investment based on AAII's A+ Investor ...